Skip to main content
SleepCited

멜라토닌 관련 일주기 리듬 장애

A

총 2,780명의 참여자를 대상으로 한 104건의 연구(메타분석 7건, RCT 6건)에 근거합니다. 104건 중 58건의 연구에서 긍정적인 효과가 나타났습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … 효과: None p<0.05

대상 집단: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … 효과: None None

대상 집단: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement 효과: None None

대상 집단: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes 효과: None None

대상 집단: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management 효과: None None

대상 집단: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

연구

4513

참여자

Mixed

A

등급

Referenced Papers

Handbook of clinical … 2025 10 인용
JAAPA : official … 2025 1 인용
Clinical psychopharmacology and … 2024 14 인용
Current neuropharmacology 2023 38 인용
Journal of clinical … 2023 6 인용
Neurologia 2022 78 인용
Archives of physiology … 2022 69 인용
Neurologia 2022 47 인용
Current neuropharmacology 2022 40 인용
Chronobiology international 2021 47 인용
Archives of medical … 2021 6 인용
Neurotherapeutics : the … 2020 80 인용
Journal of glaucoma 2020 32 인용
Current treatment options … 2020 29 인용
Current sleep medicine … 2019 28 인용
Journal of the … 2019 5 인용
Neurologic clinics 2019
Current neurology and … 2018 39 인용
Journal of sleep … 2017 1691 인용
Current biology : … 2017 455 인용
Neurological research 2017 331 인용
Continuum (Minneapolis, Minn.) 2017 132 인용
Current treatment options … 2017 56 인용
Annual review of … 2016 557 인용
Neuropsychiatric disease and … 2016 6 인용
Sleep medicine clinics 2015 75 인용
Sleep medicine clinics 2015 30 인용
Medwave 2015 6 인용
Journal of clinical … 2014 19 인용
Continuum (Minneapolis, Minn.) 2013 172 인용
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 인용
Postgraduate medicine 2011
Expert review of … 2010 58 인용
The International journal … 2010 55 인용
Travel medicine and … 2009 101 인용
Seminars in neurology 2009 17 인용
Tidsskrift for den … 2009 6 인용
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 인용
Behavioral sleep medicine 2007
The FEBS journal 2006 56 인용
Molecular and cellular … 2006 54 인용
Journal of biological … 2005 316 인용
Seminars in neurology 2004 16 인용
Journal of neuroendocrinology 2003 719 인용
Best practice & … 2003 339 인용
The Cochrane database … 2002 154 인용
Revista de neurologia 2002 35 인용
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 인용
The American journal … 2000 472 인용
Medical science monitor … 2000 11 인용
Proceedings of the … 1999 96 인용
Reproduction, nutrition, development 1999 64 인용
Current treatment options … 1999 23 인용
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 인용
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 인용
La Revue du … 1996
Journal of psychiatry … 1994 118 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

상한량: No established UL; 5 mg typically considered maximum

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

권장 복용 시간: 30-60 minutes before bed

Safety & Side Effects

보고된 부작용

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

알려진 상호작용

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

일일 최대 섭취 허용량: No established UL; 5 mg typically considered maximum

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 멜라토닌 help with 일주기 리듬 장애?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that 멜라토닌 may support 일주기 리듬 장애 management. Our evidence grade is A (Strong Evidence).
How much 멜라토닌 should I take for 일주기 리듬 장애?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 멜라토닌?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 멜라토닌 and 일주기 리듬 장애?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.